Only this pageAll pages
Powered by GitBook
1 of 10

SNOMED CT Guide for COVID-19

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Mapping to ICD-10

The following map members from SNOMED CT to the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (© World Health organisation 1994) 2016 Version are published (or will be published) in the SNOMED CT International Edition. These maps use ICD-10 codes identified in the WHO's Emergency use ICD codes for COVID-19 disease outbreak update 1.

SNOMED CT| ICD-10|

1119302008

Acute disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

U07.1

COVID-19, virus identified

MAPPED FOLLOWING WHO GUIDANCE | POSSIBLE REQUIREMENT FOR ADDITIONAL CODE TO FULLY DESCRIBE DISEASE OR CONDITION


Footnotes

1

20210131

138389411000119105

Acute bronchitis caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

U07.1

COVID-19, virus identified

MAPPED FOLLOWING WHO GUIDANCE | POSSIBLE REQUIREMENT FOR ADDITIONAL CODE TO FULLY DESCRIBE DISEASE OR CONDITION

20210131

870590002

Acute hypoxemic respiratory failure due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

U07.1

COVID-19, virus identified

MAPPED FOLLOWING WHO GUIDANCE

20210131

870589006

Acute kidney injury due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

U07.1

COVID-19, virus identified

MAPPED FOLLOWING WHO GUIDANCE

20210131

674814021000119106

Acute respiratory distress syndrome due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

U07.1

COVID-19, virus identified

MAPPED FOLLOWING WHO GUIDANCE

20210131

189486241000119100

Asymptomatic Severe acute respiratory syndrome coronavirus 2 infection (finding)

U07.1

COVID-19, virus identified

MAPPED FOLLOWING WHO GUIDANCE

20210131

119731000146105

Cardiomyopathy due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

U07.1

COVID-19, virus identified

MAPPED FOLLOWING WHO GUIDANCE

20210131

1119304009

Chronic post-COVID-19 syndrome (disorder)

U09.9

Post COVID-19 condition, unspecified

20210131

119741000146102

Conjunctivitis due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

U07.1

COVID-19, virus identified

MAPPED FOLLOWING WHO GUIDANCE

20210131

840539006

Disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

U07.1

COVID-19, virus identified

MAPPED FOLLOWING WHO GUIDANCE | POSSIBLE REQUIREMENT FOR ADDITIONAL CODE TO FULLY DESCRIBE DISEASE OR CONDITION

20210131

119981000146107

Dyspnea caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

U07.1

COVID-19, virus identified

MAPPED FOLLOWING WHO GUIDANCE

20210131

1240561000000108

Encephalopathy due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

U07.1

COVID-19, virus identified

MAPPED FOLLOWING WHO GUIDANCE

20210131

840546002

Exposure to Severe acute respiratory syndrome coronavirus 2 (event)

Z20.8

Contact with and exposure to other communicable disease

20200309

119751000146104

Fever caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

U07.1

COVID-19, virus identified

MAPPED FOLLOWING WHO GUIDANCE

20210131

1240541000000107

Infection of upper respiratory tract caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

U07.1

COVID-19, virus identified

MAPPED FOLLOWING WHO GUIDANCE

20210131

880529761000119102

Lower respiratory infection caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

U07.1

COVID-19, virus identified

MAPPED FOLLOWING WHO GUIDANCE

20210131

866151004

Lymphocytopenia due to Severe acute respiratory syndrome coronavirus 2 (disorder)

U07.1

COVID-19, virus identified

MAPPED FOLLOWING WHO GUIDANCE

20210131

1240531000000103

Myocarditis due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

U07.1

COVID-19, virus identified

MAPPED FOLLOWING WHO GUIDANCE

20210131

897036007

Occupational exposure to Severe acute respiratory syndrome coronavirus 2 (event)

Z20.8

Contact with and exposure to other communicable disease

20210131

1240521000000100

Otitis media due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

U07.1

COVID-19, virus identified

MAPPED FOLLOWING WHO GUIDANCE

20210131

882784691000119100

Pneumonia caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

U07.1

COVID-19, virus identified

MAPPED FOLLOWING WHO GUIDANCE

20210131

1119303003

Post-acute COVID-19 (disorder)

U09.9

Post COVID-19 condition, unspecified

20210131

870591003

Rhabdomyolysis due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

U07.1

COVID-19, virus identified

MAPPED FOLLOWING WHO GUIDANCE

20210131

870588003

Sepsis due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

U07.1

COVID-19, virus identified

MAPPED FOLLOWING WHO GUIDANCE

20210131

1240581000000104

Severe acute respiratory syndrome coronavirus 2 detected (finding)

U07.1

COVID-19, virus identified

20200731

866152006

Thrombocytopenia due to Severe acute respiratory syndrome coronavirus 2 (disorder)

U07.1

COVID-19, virus identified

MAPPED FOLLOWING WHO GUIDANCE

20210131

1017214008

Viremia caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

U07.1

COVID-19, virus identified

MAPPED FOLLOWING WHO GUIDANCE

20210131

http://www9.who.int/classifications/icd/covid19/en/http://www9.who.int/classifications/icd/covid19/en/

Provider and Facility Details

Information about the healthcare providers and facilities involved with the investigation, treatment, and care of patients with suspected or confirmed COVID-19 are usually recorded in electronic health records. The monitoring of medical equipment availability at healthcare facilities, such as Personal Protective Equipment (PPE) and respiratory devices, is also of utmost importance during the COVID-19 pandemic. Relevant details, which can be recorded using SNOMED CT include:

  • Healthcare profession

  • Site of care

  • Health management finding

  • Personal protective equipment

These data elements are described below, with example SNOMED CT subsets for each.

The healthcare profession is the occupation or qualification of the healthcare provider who is involved in the investigation, treatment, care or education of the patient - for example or .

CV19-PFD-HealthcareProfession Intensional Definition : <

The site of care refers to the location of the specific investigation, treatment or care setting - for example , , or .

CV19-PFD- SiteOfCare Intensional Definition : < OR << OR << OR << OR << OR <<

2.1.3 Health Management Finding

Health management finding includes concepts that describe the circumstances which affect whether the planned patient outcomes are attained, that different areas within a health organization are running appropriately, that tasks are correctly defined and assessed and that resources are used efficiently. -for example , or .

CV19-PFD- HealthManagementFinding Intensional Definition : <

Personal protective equipment is protective clothing, or other garments or equipment designed to protect the wearer's body from injury or infection - for example and

CV19-PFD- PersonalProtectiveEquipment Intensional Definition : << OR << OR << OR << OR << OR << OR << OR <<

Coding COVID-19 Related Data

The collection of coded COVID-19 related data can be critical for frontline service delivery, pandemic surveillance, and retrospective data analysis.

The following table lists a collection of data elements for which SNOMED CT can be used to capture COVID-19 related data.

Data Group| Data Element

|--- Provider and facility details([section 2.1](https://confluence.ihtsdotools.org/display/WIPCV19/2.1+Provider+and+Facility+Details?src=sidebar))|

  • Healthcare profession

  • Site of care

  • Health management finding

  • Personal protective equipment

Patient demographics

  • Biological sex

  • Gender identity

  • Marital or partnership status

  • Nationality

Clinical assessment

  • Symptoms

  • Severity

  • Clinical measurements

  • Clinical examination findings

Tests and Investigations

  • Specimen

  • Laboratory tests

  • Radiology procedures

  • Substances and virus

Prevention, treatment and education

  • Prevention

  • Prevention findings

  • Education

  • Medication

Note

The SNOMED CT subsets are provided as a guide only, and may need to be constrained or extended to meet local requirements.

How to Use this Guide

Any SNOMED CT subset used to code COVID-19 data should be designed based on its purpose and the context in which it will be used.

To make the process of planning and designing your SNOMED CT subsets more efficient and internationally consistent, we recommend the following three steps.

These three steps are explained in more detail below.

The first step is to identify the data elements that may require SNOMED CT coding. These data elements may already be defined in national reporting requirements 123, as part of a healthcare data standard you are using (e.g. a HL7 FHIR profile4 or openEHR archetypes5), or you may be developing a new information model (or data set) for this purpose. Your requirements for coded content will depend on your specific use case and the data items in your information model. In addition, different countries, regions, and hospitals may apply different clinical techniques or practices, which can also result in differing coding requirements. Therefore, deciding which subsets to implement requires clarification of the scope of content needed, by answering questions such as:

SNOMED CT COVID-19 Coding Guide

As the global terminology for health, SNOMED CT can serve as a common language for recording, sharing, integrating and analyzing COVID-19 related data. This guide provides practical examples of SNOMED CT subsets that can be used to code a variety of COVID-19 related data elements, such as symptoms, risk factors and test results. These SNOMED CT subsets can be adapted to meet local requirements for healthcare service delivery, pandemic surveillance, international collaboration and retrospective data analysis. A set of computable also accompanies this guide.



Healthcare Profession

Site of Care

Personal Protective Equipment

224547003 |Intensive therapy nurse (occupation)|
76899008 |Infectious disease specialist (occupation)|
223366009 |Healthcare professional (occupation)|
22232009 |Hospital (environment)|
309904001 |Intensive care unit (environment)|
702917005 |Respiratory disease clinic (environment)|
43741000 |Site of care (environment)|
224884006 |Location within hospital premises (environment)|
441480003 |Primary care department (environment)|
440654001 |Inpatient environment (environment)|
440655000 |Outpatient environment (environment)|
272497004 |Residential environment (environment)|
305456005 |Under care of own general practitioner (finding)|
706877002 |Problem with high complexity of treatment regime (finding)|
129837009 |Ineffective protection (finding)|
129843006 |Health management finding (finding)|
409528009 |Surgical face mask (physical object)|
255716002 |Latex rubber gloves (physical object)|
409526008 |Personal protective equipment (physical object)|
6919005 |Protective clothing material, device (physical object)|
706724001 |Face shield (physical object)|
261382003 |Mask (physical object)|
52291003 |Glove, device (physical object)|
15922004 |Gown, device (physical object)|
706154004 |Shoe cover (physical object)|
465982004 |Surgical hood (physical object)|

Ethnic group

  • Racial group

  • Occupation

  • Travel history

  • Residential location type

  • Next of kin relationship

  • Living arrangements

  • Care and support circumstances

  • Diagnosis and certainty

  • Secondary conditions and complications

  • Potential risk factors

  • Comorbidities

  • Exposure event

  • Covid-19 and viral co-infections

  • Laboratory test results

  • Other investigations

  • Administrative procedures

  • Therapeutic procedures

  • Treatment findings

  • Treatment equipment

  • What will your SNOMED CT subsets be used for?
    • Will they be used to capture new data in a clinical information system to support frontline service delivery?

    • Will they be used for disease surveillance?

    • Will they be used to integrate data from various sources?

    • Will they be used for international collaboration?

    • Will they be used for retrospective analysis of data?

  • Which data elements are required for your use case?

    • What coded data needs to be collected to support clinical care?

    • What coded data needs to be collected to provide disease surveillance?

    • What coded data needs to be shared between or integrated from different sources?

    • What coded data is required for international collaboration?

    • What coded data may be needed for retrospective data analysis?

  • What existing subsets are available for the data elements of interest?

    • Where these subsets designed based on the same or compatible requirements?

  • Answering these questions will help in understanding which of the existing subsets are relevant for your context. It may also help to identify potential content gaps in the subsets, or extraneous concepts which are not required for your specific scenario. Please note that the questions above are provided for inspiration only. Additional questions specific to your use case are likely to be needed.

    The second step is to download any available existing subsets that are associated with your required data elements.

    The example COVID-19 subsets in this guide can be downloaded from Appendix A - Example Subsets.

    The example COVID-19 subsets provided by SNOMED International have been named using the following convention.

    • SNOMED CT COVID-19 subsets:CV19- -

    • SNOMED CT COVID-19 subsets including subtypes of members:CV19- --withSubtypes

    The table below shows some examples of subsets named using this convention.

    Examples of Named Subset Category| Subset| Name Provider and Facility Details (PFD)| Site of care subset| CV19-PFD-SiteOfCare Patient Demographics (PAT)| Marital status subset| CV19-PAT-MaritalStatus Marital status subset including subtypes| CV19-PAT-MaritalStatus-withSubtypes Clinical Assessment (ASS)| Symptoms subset| CV19-ASS-Symptoms Symptoms subset including subtypes| CV19-ASS-Symptoms-withSubtypes

    The international SNOMED CT subsets have been organized into a number of categories, based on groupings of data elements that are likely to be recorded together. The five categories identified are:

    • Provider and Facility Details (PFD)

    • Patient Demographics (PAT)

    • Clinical Assessment (ASS)

    • Tests and Investigations (INV)

    • Prevention, Treatment, and Education (PTE)

    Please follow the links above for information on the specific subsets within each category.

    Some of the international subsets have been developed intensionally, while others have been developed extensionally. Please refer to the Practical Guide to Reference Sets, section 2.1.1. Subset Definitions for information on the difference between intensionally and extensionally defined subsets.

    For each extensionally-defined subset, where the members have subtypes, we provide two versions:

    1. One subset which includes only the listed members. This version supports use cases (e.g. reporting, data integration) that require more abstract concepts.

    2. One subset which includes the members listed and all the subtypes of each of these members. This version supports use cases that may require more specific values (e.g. data collection where more clinical detail is required).

      • Please note that this second type of subset is automatically generated from the corresponding subset with listed members. No manual curation has been performed, and therefore these subsets may contain concepts that are not relevant for the context of use.

    The third step is to carefully review each international subset, and adapt it to meet your specific requirements. The subsets provided represent a collection of concepts that have been contributed from a range of SNOMED International Members. It is therefore important to review each subset member to:

    1. Remove any concepts that are not required for your use case

    2. Add any concepts missing from the subset that may be required for your specific use case

      • Please note, if the concept you require is not included in the SNOMED CT Edition you are using, please follow the content request processes in each country. For more information, refer to the relevant SNOMED International Member page.

      • SNOMED International National Release Centers and other authorized users may request additions or changes to the SNOMED CT International Edition via the SNOMED CT Content Request Service. For more information, refer to the CRS User Guide or contact .

    3. Remove any concepts that are not included in the SNOMED CT versioned edition being used. This may involve

      • Checking the effective time of each international concept to ensure that it is less than or equal to the International Version used by your local SNOMED CT edition

      • Checking that any extension concepts are published in the SNOMED CT edition you are using

    4. Ensure that your subset aligns with best practice principles for subset creation.

      • For example, this may involve checking that all members of the subset belong to a single hierarchy (in most cases), and that no two members subsume each other (in most cases).

    Please note that the subsets in this guide may include some unpublished content that is planned for a future SNOMED CT edition. This content should not be used until it has been officially published, as we cannot guarantee that the identifiers or terms will not change. For this reason, these unpublished concepts are not included in the downloadable versions of the subsets. Unpublished concepts are included in this guide to assist with planning (e.g. planning of national extensions).

    Unpublished content is shown in this guide using grey, italic font on a pink background, as shown in the example below.

    In response to an immediate need for COVID-19-specific concepts, various Member countries have developed concepts within their national SNOMED CT Extensions. Please note, however, that extension concepts should only be used when the module in which they are published is included in the implemented SNOMED CT Edition. SNOMED CT extension concepts are not included in the subsets downloadable from the Reference Set tool.

    SNOMED International welcomes comments on this guide and suggestions for new or updated content. Please use the Feedback button at the bottom of each page to send us your feedback.


    Footnotes

    1 "Coronavirus Disease 2019 (COVID-19)" , Centers for Disease Control and Prevention,https://www.cdc.gov/coronavirus/2019-ncov/php/reporting-pui.html

    2 "COVID-19 Hospitalisation in England Surveillance System (CHESS) Daily Reporting,NHS - https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/03/phe-letter-to-trusts-re-daily-covid-19-hospital-surveillance-11-march-2020.pdf

    3 HISO 10082:2020 Community Based Assessment Data Standard , Wellington: Ministry of Health 2020, New Zealand

    4 Logica Implementation Guide: Covid-19 - Terminology Value Sets, U.S.

    5 openEHR Clinical Knowledge Manager (COVID-19 incubator)

    Overview

    IMPORTANT NOTE: This guide is no longer updated, and it is maintained only as a historical reference.

    Step 1 - Identify Data Elements

    Step 2 - Download Subsets

    Subset Naming Convention

    Subset Categories

    Subset Types

    Step 3 - Review and Adapt

    Unpublished Content

    Extension Content

    Feedback

    IMPORTANT NOTE: This guide is no longer updated, and it is maintained only as a historical reference.

    © Copyright 2026 International Health Terminology Standards Development Organisation, all rights reserved.

    This document is a publication of International Health Terminology Standards Development Organisation, trading as SNOMED International. SNOMED International owns and maintains SNOMED CT®.

    Any modification of this document (including without limitation the removal or modification of this notice) is prohibited without the express written permission of SNOMED International. This document may be subject to updates. Always use the latest version of this document published by SNOMED International. This can be viewed online and downloaded by following the links on the front page or cover of this document.

    SNOMED®, SNOMED CT® and IHTSDO® are registered trademarks of International Health Terminology Standards Development Organisation. SNOMED CT® licensing information is available at . For more information about SNOMED International and SNOMED International Membership, please refer to or contact us at .

    SNOMED CT subset artefacts

    Introduction

    IMPORTANT NOTE: This guide is no longer updated, and it is maintained only as a historical reference.

    Background

    On March 11, 2020, the World Health Organization formally characterized coronavirus, COVID-19, as a global pandemic and health systems globally are continuing their efforts to manage the outbreak. Coronavirus disease COVID-19 is an infectious disease caused by a newly discovered coronavirus.

    As part of the global effort to manage and contain this global public health emergency, SNOMED International is doing their part to support care teams and researchers in their efforts to address its containment. SNOMED International took swift action by publishing a set of coronavirus related concepts in the January 31st 2020 International Edition of SNOMED CT, with updated descriptions and SNOMED CT to ICD-10 maps in the interim March 2020 International Edition release. Since then, SNOMED International has published additional COVID-19 related content requested by the international community. This SNOMED CT Coronavirus Content will be made available as part of the Global Patient Set (GPS) in the September 2020 GPS release. In the meantime, this content is available and can be used under the same open license as the GPS, the Creative Commons Attribution 4.0 International License.

    Purpose

    As the global terminology for health, SNOMED CT can serve as a common language for recording, sharing, integrating and analyzing COVID-19 related data. This guide provides practical examples of SNOMED CT subsets that can be used to code a variety of COVID-19 related data elements, such as symptoms, risk factors and test results. These SNOMED CT subsets can be adapted to meet local requirements for healthcare service delivery, pandemic surveillance, international collaboration and retrospective data analysis. A set of computable SNOMED CT subset artefacts also accompanies this guide.

    For more information on performing data analytics using SNOMED CT please refer to Data Analytics with SNOMED CT. Additional guidance can be found in the SNOMED CT Document Library.

    The scope of this document has been guided by the collective needs and experiences of our SNOMED International Members.

    The primary focus of the guide is to provide example SNOMED CT subsets for data elements covering the following key areas:

    • Provider and facility details - e.g. healthcare profession, site of care, personal protective equipment

    • Patient demographics - e.g. biological sex, foreign travel history, living arrangements

    • Clinical assessment - e.g. symptoms, diagnosis, complications

    These subsets provide examples of SNOMED CT concepts that may be used to code data elements in national reporting requirements, as part of a healthcare data standard (e.g. a HL7 FHIR profile or openEHR archetype), or a newly developed information model (data set). Before they can be used in a production system, these subsets should be carefully reviewed and updated to ensure that they fully meet the requirements of the intended use case.

    The example subsets included in this guide use concepts that are in (or are planned to be added to) the SNOMED CT International Edition. This provides a foundation for international collaboration and research on COVID-19. Some examples of SNOMED CT extension concepts, added in National Editions of SNOMED CT, are also provided for a number of data elements. Please note that all concepts referenced in this guide should be used only in implementations where the relevant Edition is deployed.

    The primary audience of this guide is the SNOMED National Release Centers (NRCs), who themselves may be required to provide national or regional guidance to their local implementations during or after the COVID-19 pandemic.

    This guide has been developed in collaboration with our SNOMED National Release Centers (NRCs) and other Member representatives. We would like to thank you all for sharing your knowledge and experience to collectively help in the development of this COVID-19 guide.

    The following references were used in the development of this guide.

    • , IFIC Basic Concepts of Infection Control (Chapter 6), 3rd edition, 2016, International Federation of Infection Control

    • , Centers for Disease Control and Prevention, U.S.

    Patient Demographics

    General demographic characteristics are important to record for each patient being investigated or treated for COVID-19. Relevant patient demographics, which can be recorded using SNOMED CT includes:

    • Biological sex

    • Gender identity

    Tests and procedures - e.g. specimen, laboratory test results
  • Treatment and education - e.g. vaccination, therapy

  • Coronavirus Disease (COVID-19) Pandemic , World Health Organization
  • Coronavirus: what are asymptomatic and mild COVID-19?, Patient.info

  • Coronavirus: what are moderate, severe and critical COVID-19?, Patient.info

  • COVID-19 and the Cardiovascular System

  • COVID-19 Dataset Specification, Feidhmeannacht na Seirbhise Slainte, Health Service Executive, Ireland.

  • COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission

  • COVID-19 Hospitalisation in England Surveillance System (CHESS) Daily Reporting, NHS, UK

  • COVID-19 Penomics, UCL, Health Data Research UK.

  • COVID-19 Response Home, HL7 International

  • Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China

  • Emergency use ICD codes for COVID-19 disease outbreak , World Health Organization

  • Global Research on Coronavirus Disease (COVID-19), World Health Organization

  • Guidance document on appropriate management of suspect/confirmed cases of COVID-19 - Types of Covid-19 dedicated facilities, Ministry of Health and Family Welfare (MoHFW), Govt. of India

  • HISO 10082:2020 Community Based Assessment Data Standard , Wellington: Ministry of Health 2020, New Zealand

  • Holistic care for patients with severe coronavirus disease 2019: An expert consensus, International Journal of Nursing Sciences, Volume 7, Issue 2, 10 April 2020, Pages 128-134

  • Interoperability for COVID-19 Novel Coronavirus Pandemic , The Office of the National Coordinator for Health Information Technology, U.S.

  • Logica Implementation Guide: Covid-19 - Terminology Value Sets, U.S.

  • Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: A Retrospective Case Series Study

  • Novel Coronavirus (COVID-19) Case Record Form, Global COVID-19 Clinical Platform, World Health Organization

  • openEHR Clinical Knowledge Manager (COVID-19 incubator)

  • Revised National Clinical Management Guidelines for COVID-19, Ministry of Health and Family Welfare (MoHFW), Govt. of India

  • Rhabdomyolysis as Potential Late Complication Associated with COVID-19

  • SARS Coronavirus 2, Regenstrief Institute

  • SNOMED CT Coronavirus Content, _SNOMED International

  • Solidarity Clinical Trials for COVID-19 Treatment, World Health Organization

  • Standard Operating Procedure (SOP) for transporting a suspect/confirmed case of COVID-19, Ministry of Health and Family Welfare (MoHFW), Govt of India.

  • Scope

    Audience

    Acknowledgments

    References

    Audits in Infection Prevention and Control
    Caution on Kidney Dysfunctions of COVID-19 Patients
    Coronavirus Disease 2019 (COVID-19)
    info@snomed.org
    Marital or partnership status
  • Nationality

  • Ethnic group

  • Racial group

  • Occupation

  • Travel history

  • Residential location type

  • Next of kin relationship

  • Living arrangements

  • Care and support circumstances

  • These data elements are described below, with example SNOMED CT subsets for each.

    Multiple types of sex and/or gender are recorded in clinical practice, including biological sex and gender identity. 1

    SNOMED CT supports the distinction between biological sex (e.g. 248152002 |Female (finding)| ) and gender identity (e.g. 703118005 |Feminine gender (finding)| ), as shown in the two subset definitions below.

    CV19-PAT- BiologicalSex Intensional Definition : < 429019009 |Finding related to biological sex (finding)| MINUS << 302081005 |Finding of sex of baby (finding)|

    CV19-PAT- GenderIdentity Intensional Definition : < 365873007 |Gender finding (finding)|

    The marital or partnership status of a patient describes their legal, civil or personal relationship with their significant other, for example 87915002 | Married (finding)| .

    CV19-PAT- MaritalOrPartnershipStatus Intensional Definition : < 365581002 |Finding of marital or partnership status (finding)|

    Nationality refers to a particular legal relationship between an individual person and a sovereign state. The nationality of a patient may refer to the nation in which they were born, have citizenship, or have other legal ties - for example 223610001 | Jordan (geographic location)| or 223625001 | New Zealand (geographic location)| .

    CV19-PAT- Nationality Intensional Definition : < 223369002 |Country (geographic location)|

    The ethnic group (or ethnicity) of a patient is the social or cultural group with whom they identify - for example, 33897005 |Chinese (ethnic group)| or 735001008 |Scandinavian (ethnic group)| .

    CV19-PAT- EthnicGroup Intensional Definition : < 372148003 |Ethnic group (ethnic group)|

    The racial group (or race) of a patient is the group (or groups) with whom they share inherited physical characteristics - for example, 414408004 |Hispanic (racial group)| or 413773004 |Caucasian (racial group)| .

    CV19-PAT- RacialGroup Intensional Definition : < 415229000 |Racial group (racial group)|

    Occupation is the patient's job or profession - for example, 158942005 | Residential child care worker (occupation)| or 308223007 | Hairdresser (occupation)| .

    CV19-PAT- Occupation Intensional Definition : < 14679004 |Occupation (occupation)|

    The travel history of a patient is a record of their past visits to locations both inside and outside their country of residence. This may include a list of the specific countries and/or regions that they have travelled to (e.g. 223498002 | Africa (geographic location)| or 223585008 | South east Asian country (geographic location)| ), or a descriptive travel history finding (e.g. 161090005 | Travel abroad for business (finding)| ).

    CV19-PAT-TravelHistory Intensional Definition : < 223496003 |Geographical and/or political region of the world (geographic location)| OR < 365457007 |Foreign travel history finding (finding)| OR < 420008001 |Travel (event)|

    The residential location type is the type of place in which the patient is currently living, or was living prior to admission to hospital - for example, 257564005 | Apartment (environment)| or 257670006 | Private house (environment)| .

    CV19-PAT- ResidentialLocationType Intensional Definition : < 272497004 |Residential environment (environment)|

    The next of kin relationship is the relationship that the patient has with their closest living relative (as chosen by the patient) - for example 444053001 | Husband of subject (person)| or 444301002 | Mother of subject (person)| .

    CV19-PAT- NextOfKinRelationship Intensional Definition : < 444148008 |Person in family of subject (person)|

    The living arrangements of the patient describes the familial and non-familial relationships of a person to all the other people with whom they usually reside - for example 105529008 | Lives alone (finding)| or 224133007 | Lives with family (finding)| .

    CV19-PAT- LivingArrangements Intensional Definition : < 365481000 |Finding of household composition (finding)|

    The care and support circumstances of the patient describe how and by whom they are looked after when living at their usual place of residence - for example 427454004 | Cared for by neighbors (finding)| or 301887005 | Needs assistance at home (finding)| .

    CV19-PAT- CareAndSupportCircumstances Intensional Definition : < 365483002 |Finding related to care and support circumstances and networks (finding)|


    Footnotes

    1 https://confluence.hl7.org/display/VOC/The+Gender+Harmony+Project

    Sex and Gender

    Marital or Partnership Status

    Nationality

    Ethnic Group

    Racial Group

    Occupation

    Travel History

    Residential Location Type

    Next of Kin Relationship

    Living Arrangements

    Care and Support Circumstances

    http://snomed.org/licensing
    http://www.snomed.org
    info@snomed.org
    Introduction
    Coding COVID-19 Related Data
    Mapping to ICD-10

    Tests and Investigations

    Laboratory testing for COVID-19 and the associated SARS-CoV-2 virus includes methods that detect the presence of the virus and antibodies produced in response to infection, in specimen samples taken from potentially infected individuals. Test and investigation data which can be recorded using SNOMED CT includes:

    • Specimen

    • Laboratory Tests

    • Radiology Procedures

    • Substances and Virus

    • Laboratory Test Results

    • Other Investigations

    These data elements are described below, with example SNOMED CT subsets for each.

    Specimens are samples of substances taken from an individual for testing - for example or . The following specimens may be relevant to COVID-19 testing in one or more countries affected by the virus.

    CV19-INV-Specimen

    • The specimens prefixed with a star '*' are a subtype of another member of this subset.

    Laboratory tests can be performed to detect the presence of the COVID-19 virus and antibodies produced in response to this virus. The following SNOMED CT concepts can be used to record laboratory tests that may be performed during the investigation process.

    CV19-INV-LaboratoryTests

    Radiology procedures are procedures that obtain images of the inside of the body. The following SNOMED CT concepts may be used to record radiology procedures that may be performed during the investigation and treatment of suspected or confirmed Covid-19 patients.

    CV19-INV-RadiologyProcedures

    An antibody is a protective protein produced by the immune system in response to the presence of a foreign substance, called an antigen. The following antibody/antigen and virus organism concepts can be used to record the focus of a COVID-19 investigation.

    CV19-INV-SubstancesAndVirus

    Laboratory test results are used to specify whether the Laboratory test focus was detected or not detected following the conducted laboratory test. The following qualifier values may be used for this purpose.

    CV19-INV-LabTestResults

    Other investigative procedures - e.g. and and and - may be performed to assess a COVID-19 patient. The following subset represents procedures that can be performed during the clinical assessment process.

    The following subset represents a collection of findings with context that may be related to these investigations and captured using SNOMED CT - for example or .


    Footnotes

    1 , Division of Laboratory Systems, CDC, US

    2 , The Native Antigen Company, UK

    119297000

    Blood specimen (specimen)

    Blood specimen

    20040731

    *

    258607008

    Bronchoalveolar lavage fluid sample (specimen)

    Bronchoalveolar lavage fluid sample

    20080731

    *

    122554006

    Capillary blood specimen (specimen)

    Capillary blood specimen

    20080731

    *

    119294007

    Dried blood specimen (specimen)

    Dried blood specimen

    20020131

    168137004

    Gastric aspirate sample (specimen)

    Gastric aspirate sample

    20060131

    258606004

    Lower respiratory sample (specimen)

    Lower respiratory sample

    20080731

    258411007

    Nasopharyngeal aspirate (specimen)

    Nasopharyngeal aspirate

    20080731

    258500001

    Nasopharyngeal swab (specimen)

    Nasopharyngeal swab

    20080731

    258412000

    Oropharyngeal aspirate (specimen)

    Oropharyngeal aspirate

    20080731

    418564007

    Pleural fluid specimen (specimen)

    Pleural fluid specimen

    20080731

    119342007

    Saliva specimen (specimen)

    Saliva specimen

    20040731

    *

    119364003

    Serum specimen (specimen)

    Serum specimen

    20050131

    734427005

    Specimen from duodenum obtained by aspiration (specimen)

    Specimen from duodenum obtained by aspiration

    20180131

    122610009

    Specimen from lung obtained by biopsy (specimen)

    Specimen from lung obtained by biopsy

    20080731

    445447003

    Specimen from trachea obtained by aspiration (specimen)

    Specimen from trachea obtained by aspiration

    20100731

    119334006

    Sputum specimen (specimen)

    Sputum specimen

    20080731

    119339001

    Stool specimen (specimen)

    Stool specimen

    20030731

    *

    472901003

    Swab from nasal sinus (specimen)

    Swab from nasal sinus

    20130131

    445297001

    Swab of internal nose (specimen)

    Swab of internal nose

    20100731

    *

    871810001

    Swab specimen from nasal mid-turbinate (specimen)

    Mid-turbinate nasal swab

    20200731

    461911000124106

    Swab specimen from oropharynx (specimen)

    Oropharyngeal swab

    20200731

    258529004

    Throat swab (specimen)

    Throat swab

    20080731

    122877000

    Upper respiratory fluid specimen obtained by tracheal aspiration (specimen)

    Upper respiratory fluid specimen obtained by tracheal aspiration

    20040731

    309164002

    Upper respiratory swab sample (specimen)

    Upper respiratory swab sample

    20080731

    122575003

    Urine specimen (specimen)

    Urine specimen

    20080731

    *

    258580003

    Whole blood sample (specimen)

    Whole blood sample

    20080731

    Analysis of arterial blood gases and pH (procedure)

    Analysis of arterial blood gases and pH

    20020131

    444077007

    Analysis using reverse transcriptase polymerase chain reaction technique (procedure)

    Analysis using reverse transcriptase PCR

    20100131

    61911006

    Blood gases, venous measurement (procedure)

    Blood gases, venous measurement

    20020131

    871555000

    Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 (observable entity)

    Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2

    20200731

    871559006

    Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 in bronchoalveolar lavage fluid (observable entity)

    Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 in bronchoalveolar lavage fluid

    20200731

    871556004

    Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 in nasopharyngeal swab (observable entity)

    Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 in nasopharyngeal swab

    20200731

    871557008

    Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 in oropharyngeal swab (observable entity)

    Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 in oropharyngeal swab

    20200731

    871558003

    Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 in sputum (observable entity)

    Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 in sputum

    20200731

    871560001

    Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 using polymerase chain reaction (observable entity)

    Detection of ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 using polymerase chain reaction

    20200731

    871562009

    Detection of Severe acute respiratory syndrome coronavirus 2 (observable entity)

    Detection of Severe acute respiratory syndrome coronavirus 2

    20200731

    871553007

    Detection of Severe acute respiratory syndrome coronavirus 2 antigen (observable entity)

    Detection of Severe acute respiratory syndrome coronavirus 2 antigen

    20200731

    76978006

    Enzyme-linked immunosorbent assay (procedure)

    Enzyme-linked immunosorbent assay

    20080731

    30662005

    Fluorescent immunoassay (procedure)

    Fluorescent immunoassay

    20020131

    414464004

    Immunoassay method (procedure)

    Immunoassay method

    20050131

    1240461000000109

    Measurement of severe acute respiratory syndrome coronavirus 2 antibody (observable entity)

    Measurement of severe acute respiratory syndrome coronavirus 2 antibody

    20200731

    1240471000000102

    Measurement of severe acute respiratory syndrome coronavirus 2 antigen (observable entity)

    Measurement of severe acute respiratory syndrome coronavirus 2 antigen

    20200731

    122435008

    Measurement of viral antibody (procedure)

    Measurement of viral antibody

    20100131

    9718006

    Polymerase chain reaction analysis (procedure)

    Polymerase chain reaction analysis

    20080731

    122433001

    Viral antigen assay (procedure)

    Viral antigen assay

    20050131

    118147004

    Viral nucleic acid assay (procedure)

    Viral nucleic acid assay

    20020131

    88667002

    Viral serologic study (procedure)

    Viral serologic study

    20150131

    Computed tomography of chest (procedure)

    CT of chest

    20040731

    399208008

    Plain chest X-ray (procedure)

    Plain chest X-ray

    20050131

    88628008

    Ultrasonography of lung (procedure)

    Ultrasonography of lung

    20020131

    Antigen of severe acute respiratory syndrome coronavirus 2 (substance)

    Antigen of SARS-CoV-2

    20200131

    870361009

    Immunoglobulin G antibody to Severe acute respiratory syndrome coronavirus 2 (substance)

    SARS-CoV-2 IgG

    20200731

    870362002

    Immunoglobulin M antibody to Severe acute respiratory syndrome coronavirus 2 (substance)

    SARS-CoV-2 IgM

    20200731

    1155866009

    Messenger ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 encoding spike protein (substance)

    SARS-CoV-2 mRNA encoding spike protein

    20210731

    1119343008

    Messenger ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 (substance)

    Severe acute respiratory syndrome coronavirus 2 mRNA

    20210131

    1240411000000107

    Ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 (substance)

    Severe acute respiratory syndrome coronavirus 2 RNA

    20200731

    840533007

    Severe acute respiratory syndrome coronavirus 2 (organism)

    SARS-CoV-2

    20200131

    Inconclusive (qualifier value)

    Inconclusive

    20060131

    260415000

    Not detected (qualifier value)

    Not detected

    20020131

    895231008

    Not detected in pooled specimen (qualifier value)

    Not detected in pooled specimen

    20200731

    897035006

    Severe acute respiratory syndrome coronavirus 2 antibody test negative (finding)

    SARS-CoV-2 antibody test negative

    20210131

    897034005

    Severe acute respiratory syndrome coronavirus 2 antibody test positive (finding)

    SARS-CoV-2 antibody test positive

    20210131

    1240581000000104

    Severe acute respiratory syndrome coronavirus 2 detected (finding)

    Severe acute respiratory syndrome coronavirus 2 detected

    20200731

    1240591000000102

    Severe acute respiratory syndrome coronavirus 2 not detected (finding)

    Severe acute respiratory syndrome coronavirus 2 not detected

    20200731

    125154007

    Specimen unsatisfactory for evaluation (finding)

    Specimen unsatisfactory for evaluation

    20020131

    Concept id

    Fully Specified Name

    en-US Preferred Term

    Effective Time

    *

    697989009

    Anterior nares swab (specimen)

    Anterior nares swab

    Concept id

    Fully Specified Name

    en-US Preferred Term

    Effective Time

    Concept id

    Fully Specified Name

    en-US Preferred Term

    Effective Time

    16332841000119106

    Computed tomography angiography of pulmonary artery with contrast (procedure)

    CT angiography of pulmonary artery with contrast

    20170131

    Concept id

    Fully Specified Name

    en-US Preferred Term

    Effective Time

    840535000

    Antibody to severe acute respiratory syndrome coronavirus 2 (substance)

    Antibody to SARS-CoV-2

    20200131

    Concept id

    Fully Specified Name

    en-US Preferred Term

    Effective Time

    260373001

    Detected (qualifier value)

    Detected

    20020131

    CV19-INV-InvestigationProcedures

    Intensional Definition:

    < 386053000 |Evaluation procedure (procedure)| OR < 308335008 |Patient encounter procedure (procedure)| OR < 17636008 |Specimen collection (procedure)|

    CV19-INV-InvestigationFindings

    Intensional Definition:

    < 313333008 |Sample obtained (situation)| OR < 168123008 |Sample sent for examination (situation)|

    Specimen

    Laboratory Tests

    Radiology Procedures

    Substances and Virus

    Laboratory Test Results

    Other Investigations

    258500001 | Nasopharyngeal swab (specimen)|
    119339001 | Stool specimen (specimen)|
    719410009 | Consultation via video conference (procedure)|
    386472008 | Telephone consultation (procedure)|
    243791004 | Viral screening (procedure)|
    29303009 | Electrocardiographic procedure (procedure)|
    269944001 | Nasal swab taken (situation)|
    168331006 | Blood sent for virology (situation)|
    LOINC In Vitro Diagnostic (LIVD) Test Code Mapping for SARS-CoV-2 Tests
    Why We Need Antigen and Antibody Tests for COVID-19

    20140131

    60170009

    169069000

    840536004

    419984006

    Prevention, Treatment and Education

    Preventing the potential spread of COVID-19 can involve a range of precautions, such as isolation and the wearing of personal protective equipment, and education to patients, healthcare workers and the broader community. Once COVID-19 is diagnosed, various treatments may be considered, together with education for the patient and their families/caregivers

    • Prevention

    • Prevention Findings

    • Education

    • Medication

    • Administrative Procedures

    • Therapeutic Procedures

    • Treatment Findings

    • Treatment Equipment

    These data elements are described below, with example SNOMED CT subsets where applicable.

    Precautionary measures, such as , , and are extremely important in the fight against infectious diseases such as COVID-19. The following preventative measures can be recorded using SNOMED CT.

    CV19-PTE-PreventionProcedures

    Clinical findings (or situations) relating to the COVID-19 preventative measures performed may be captured in a health record. The following prevention findings (or situations) may be recorded using SNOMED CT.

    CV19-PTE-PreventionFindings

    Education is an important aspect of preventing and managing COVID-19 infection. The following SNOMED CT concepts may be used to record this data.

    CV19-PTE-Education

    A number of countries are trialling the use of medication to treat COVID-19. Many of these medications can be found in the hierarchy of SNOMED CT. However until there is sufficient evidence, the WHO is cautioning against associations recommending or administering these unproven treatments to patients with COVID-19 or people self-medicating with them. For this reason, we have not included a medication treatment subset at this time.

    COVID-19 vaccines, however, have been proven to be effective in clinical trials. The following generic vaccine concepts may be recorded using SNOMED CT.

    CV19-PTE-Vaccines

    Patients with severe symptoms or complications may require admission to hospital, or other administrative procedures. The following administrative procedures may be recorded using SNOMED CT.

    CV19-PTE-AdministrativeProcedures

    Patients suffering from severe COVID-19 symptoms or complications may require a range of therapeutic procedures, many of them involving supportive care to help them breathe. The following therapeutic procedures may be recorded using SNOMED CT.

    CV19-PTE-TherapeuticProcedures

    Clinical findings relating to the treatment performed on a patient may be captured in a health record. The following treatment findings may be recorded using SNOMED CT.

    CV19-PTE-TreatmentPreventionFindings

    Respiratory equipment includes those medical devices used to support breathing and respiratory function - for example , and .


    Footnotes

    1 , IFIC Basic Concepts of Infection Control (Chapter 6), 3rd edition, 2016, International Federation of Infection Control

    2

    Administration of first dose of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)

    Administration of first dose of SARS-CoV-2 mRNA vaccine

    20210131

    1157197009

    Administration of second dose of vaccine product containing only inactivated whole Severe acute respiratory syndrome coronavirus 2 antigen (procedure)

    Administration of second dose of inactivated whole SARS-CoV-2 antigen vaccine

    20210731

    1157108008

    Administration of second dose vaccine product containing only recombinant non-replicating viral vector encoding Severe acute respiratory syndrome coronavirus 2 spike protein (procedure)

    Administration of second dose SARS-CoV-2 non-replicating viral vector vaccine

    20210731

    1144998002

    Administration of second dose of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)

    Administration of second dose of SARS-CoV-2 mRNA vaccine

    20210131

    1162646009

    Administration of second dose of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure)

    Administration of second dose of SARS-CoV-2 recombinant spike protein antigen vaccine

    20210731

    1156257007

    Administration of vaccine product against Severe acute respiratory syndrome coronavirus 2 (procedure)

    Administration of SARS-CoV-2 vaccine

    20210731

    1157107003

    Administration of vaccine product containing only recombinant non-replicating viral vector encoding Severe acute respiratory syndrome coronavirus 2 spike protein (procedure)

    Administration of SARS-CoV-2 non-replicating viral vector vaccine

    20210731

    840534001

    Administration of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 antigen (procedure)

    Administration of SARS-CoV-2 antigen vaccine

    20210131

    1119350007

    Administration of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)

    Administration of SARS-CoV-2 mRNA vaccine

    20210131

    1162645008

    Administration of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure)

    Administration of SARS-CoV-2 recombinant spike protein antigen vaccine

    20210731

    409524006

    Airborne precautions (procedure)

    Airborne precautions

    20040731

    422181004

    Antibiotic prophylaxis (procedure)

    Antibiotic prophylaxis

    20060731

    449399005

    Application of personal protective equipment (procedure)

    Application of personal protective equipment

    20110731

    386242000

    Communicable disease management (procedure)

    Communicable disease management

    20030131

    225368008

    Contact tracing (procedure)

    Contact tracing

    20020131

    409529001

    Contact precautions (procedure)

    Contact precautions

    20040731

    409686004

    Disinfecting of equipment (procedure)

    Disinfecting of equipment

    20040731

    449390009

    Ensuring use of supplies and equipment within safe parameters (procedure)

    Ensuring use of supplies and equipment within safe parameters

    20110731

    122467006

    Fitting procedure (procedure)

    Fitting procedure

    20020131

    77248004

    Infection control procedure (procedure)

    Infection control procedure

    20020131

    370832005

    Initiation of traffic control (procedure)

    Initiation of traffic control

    20020731

    361235007

    Isolation of infected patient (procedure)

    Isolation of infected patient

    20020131

    170499009

    Isolation of infection contact (procedure)

    Isolation of infection contact

    20020131

    170500000

    Isolation of infection carrier (procedure)

    Isolation of infection carrier

    20020131

    40174006

    Isolation procedure (procedure)

    Isolation technique

    20020131

    225995005

    Maintaining a safe environment (procedure)

    Maintaining a safe environment

    20020131

    275827007

    Maintaining asepsis (procedure)

    Maintaining asepsis

    20020131

    38883000

    Preoperative disinfection of skin (procedure)

    Preoperative disinfection of skin

    20020131

    29537000

    Preoperative shaving of skin (procedure)

    Preoperative shaving of skin

    20080131

    736762004

    Provision of personal protective equipment (procedure)

    Provision of personal protective equipment

    20180131

    409525007

    Respiratory secretion precautions (procedure)

    Respiratory secretion precautions

    20040731

    410410006

    Screening surveillance (regime/therapy)

    Screening surveillance

    20040731

    409522005

    Standard precautions (procedure)

    Standard precautions

    20040731

    409684001

    Sterilization of equipment (procedure)

    Sterilization of equipment

    20040731

    409583003

    Transmission-based precautions (procedure)

    Transmission-based precautions

    20040731

    243791004

    Viral screening (procedure)

    Viral screening

    20080131

    Adverse reaction to component of vaccine product containing only inactivated whole Severe acute respiratory syndrome coronavirus 2 antigen (disorder)

    Adverse reaction to inactivated whole COVID-19 antigen vaccine

    20210731

    1157106007

    Adverse reaction to component of vaccine product containing only recombinant non-replicating viral vector encoding Severe acute respiratory syndrome coronavirus 2 spike protein (disorder)

    Adverse reaction to COVID-19 non-replicating viral vector vaccine

    20210731

    1142182006

    Adverse reaction to component of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 antigen (disorder)

    Adverse reaction to COVID-19 antigen vaccine

    20210131

    1142181004

    Adverse reaction to component of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (disorder)

    Adverse reaction to COVID-19 mRNA vaccine

    20210131

    1162644007

    Adverse reaction to component of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (disorder)

    Adverse reaction to COVID-19 recombinant spike protein antigen vaccine

    20210731

    1145003007

    Hypersensitivity to vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (finding)

    Hypersensitivity to SARS-CoV-2 mRNA vaccine

    20210131

    1157198004

    Inactivated whole Severe acute respiratory syndrome coronavirus 2 antigen vaccine contraindicated (situation)

    Inactivated whole SARS-CoV-2 antigen vaccine contraindicated

    20210731

    1157200005

    Inactivated whole Severe acute respiratory syndrome coronavirus 2 antigen vaccine declined (situation)

    Inactivated whole SARS-CoV-2 antigen vaccine declined

    20210731

    1157199007

    Second dose of inactivated whole Severe acute respiratory syndrome coronavirus 2 antigen vaccine contraindicated (situation)

    Second dose of inactivated whole SARS-CoV-2 antigen vaccine contraindicated

    20210731

    1157201009

    Second dose of inactivated whole Severe acute respiratory syndrome coronavirus 2 antigen vaccine declined (situation)

    Second dose of inactivated whole SARS-CoV-2 antigen vaccine declined

    20210731

    1145035007

    Second dose of Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine contraindicated (situation)

    Second dose of SARS-CoV-2 mRNA vaccine contraindicated

    20210131

    1145034006

    Second dose of Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine declined (situation)

    Second dose of SARS-CoV-2 mRNA vaccine declined

    20210131

    1157113007

    Second dose of Severe acute respiratory syndrome coronavirus 2 non-replicating viral vector vaccine contraindicated (situation)

    Second dose of SARS-CoV-2 non-replicating viral vector vaccine contraindicated

    20210731

    1157120000

    Second dose of Severe acute respiratory syndrome coronavirus 2 non-replicating viral vector vaccine declined (situation)

    Second dose of SARS-CoV-2 non-replicating viral vector vaccine declined

    20210731

    1162648005

    Second dose of Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccine contraindicated (situation)

    Second dose of recombinant spike protein SARS-CoV-2 antigen vaccine contraindicated

    20210731

    1162650002

    Second dose of Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccine declined (situation)

    Second dose of SARS-CoV-2 recombinant spike protein antigen vaccine declined

    20210731

    1145031003

    Severe acute respiratory syndrome coronavirus 2 antigen or Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine declined (situation)

    SARS-CoV-2 vaccine declined

    20210131

    1145023008

    Severe acute respiratory syndrome coronavirus 2 antigen vaccine contraindicated (situation)

    SARS-CoV-2 antigen vaccine contraindicated

    20210131

    1145033000

    Severe acute respiratory syndrome coronavirus 2 antigen vaccine declined (situation)

    SARS-CoV-2 antigen vaccine declined

    20210131

    1145030002

    Severe acute respiratory syndrome coronavirus 2 antigen vaccination not indicated (situation)

    SARS-CoV-2 antigen vaccination not indicated

    20210131

    1145022003

    Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine contraindicated (situation)

    SARS-CoV-2 mRNA vaccine contraindicated

    20210131

    1145032005

    Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine declined (situation)

    SARS-CoV-2 mRNA vaccine declined

    20210131

    1145029007

    Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccination not indicated (situation)

    SARS-CoV-2 mRNA vaccination not indicated

    20210131

    1157110005

    Severe acute respiratory syndrome coronavirus 2 non-replicating viral vector vaccine contraindicated (situation)

    SARS-CoV-2 non-replicating viral vector vaccine contraindicated

    20210731

    1157118003

    Severe acute respiratory syndrome coronavirus 2 non-replicating viral vector vaccine declined (situation)

    SARS-CoV-2 non-replicating viral vector vaccine declined

    20210731

    1162647000

    Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccine contraindicated (situation)

    SARS-CoV-2 recombinant spike protein antigen vaccine contraindicated

    20210731

    1162649002

    Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccine declined (situation)

    SARS-CoV-2 recombinant spike protein antigen vaccine declined

    20210731

    1156270003

    Severe acute respiratory syndrome coronavirus 2 vaccination declined (situation)

    SARS-CoV-2 vaccination declined

    20210731

    1156267002

    Severe acute respiratory syndrome coronavirus 2 vaccination not indicated (situation)

    SARS-CoV-2 vaccination not indicated

    20210731

    1156265005

    Severe acute respiratory syndrome coronavirus 2 vaccine contraindicated (situation)

    SARS-CoV-2 vaccine contraindicated

    20210731

    1156746003

    Vaccine-induced prothrombotic immune thrombocytopenia (disorder)

    Vaccine-induced prothrombotic immune thrombocytopenia

    20210731

    Education about infectious disease (procedure)

    Education about infectious disease

    20200731

    223426009

    Equipment use education (procedure)

    Equipment use education

    20020131

    698608004

    Hand washing education (procedure)

    Hand washing education

    20140131

    385820004

    Infection control education (procedure)

    Infection control education

    20100731

    Vaccine product containing only inactivated whole Severe acute respiratory syndrome coronavirus 2 antigen (medicinal product)

    Inactivated whole SARS-CoV-2 antigen vaccine

    20210731

    29061000087103

    Vaccine product containing only recombinant non-replicating viral vector encoding Severe acute respiratory syndrome coronavirus 2 spike protein (medicinal product)

    COVID-19 non-replicating viral vector vaccine

    20210731

    1119305005

    Vaccine product containing only Severe acute respiratory syndrome coronavirus 2 antigen (medicinal product)

    Severe acute respiratory syndrome coronavirus 2 antigen only vaccine product

    20210131

    1119349007

    Vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (medicinal product)

    Severe acute respiratory syndrome coronavirus 2 mRNA only vaccine product

    20210131

    1162643001

    Vaccine product containing only Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (medicinal product)

    SARS-CoV-2 recombinant spike protein antigen vaccine

    20210731

    Admission to infectious diseases department (procedure)

    Admission to infectious diseases department

    20020131

    305351004

    Admission to intensive care unit (procedure)

    Admission to intensive care unit

    20020131

    305360007

    Admission to respiratory medicine department (procedure)

    Admission to respiratory medicine department

    20020131

    32485007

    Hospital admission (procedure)

    Hospital admission

    20020131

    417005

    Hospital re-admission (procedure)

    Hospital re-admission

    20020131

    107724000

    Patient transfer (procedure)

    Patient transfer

    20020131

    397821002

    Patient transfer to intensive care unit (procedure)

    Patient transfer to intensive care unit

    20030731

    710112000

    Transfer of care from hospital (procedure)

    Transfer of care from hospital

    20150731

    429202003

    Transfer of care to hospital (procedure)

    Transfer of care to hospital

    20080131

    Extracorporeal membrane oxygenation (procedure)

    Extracorporeal membrane oxygenation

    20020131

    697984004

    Exteriorization of trachea (procedure)

    Exteriorization of trachea

    20140131

    229301009

    Incentive spirometry (regime/therapy)

    Incentive spirometry

    20020131

    829831000000100

    Insertion of fiducial marker into lung using computed tomography guidance (procedure)

    Insertion of fiducial marker into lung using computed tomography guidance

    20200731

    447996002

    Intubation of respiratory tract (procedure)

    Intubation of respiratory tract

    20110731

    243141005

    Mechanically assisted spontaneous ventilation (procedure)

    Mechanically assisted spontaneous ventilation

    20020131

    428311008

    Noninvasive ventilation (procedure)

    Noninvasive ventilation

    20080131

    371908008

    Oxygen administration by mask (procedure)

    Oxygen administration by mask

    20020731

    371907003

    Oxygen administration by nasal cannula (procedure)

    Oxygen administration by nasal cannula

    20020731

    431182000

    Placing subject in prone position (procedure)

    Placing subject in prone position

    20080731

    11140008

    Respiratory assist, manual (procedure)

    Respiratory assist, manual

    20020131

    1156748002

    Transfusion of convalescent plasma into central vein (procedure)

    Transfusion of convalescent plasma into central vein

    20210731

    1156747007

    Transfusion of convalescent plasma into peripheral vein (procedure)

    Transfusion of convalescent plasma into peripheral vein

    20210731

    Dependence on supplemental oxygen (finding)

    Dependence on supplemental oxygen

    20120731

    444932008

    Dependence on ventilator (finding)

    Dependence on ventilator

    20100731

    763326004

    Difficult mask ventilation (finding)

    Difficult mask ventilation

    20180731

    718447001

    Difficult tracheal intubation (finding)

    Difficult intubation

    20160731

    419991009

    Endotracheal tube present (finding)

    Endotracheal tube present

    20060131

    405496006

    Inability to ventilate patients lungs mechanically (finding)

    Inability to ventilate patients lungs mechanically

    20040131

    22803001

    Normal respiratory function (finding)

    Normal respiratory function

    20020131

    371825009

    Patient on oxygen (finding)

    Patient on oxygen

    20020731

    371820004

    Patient ventilated (finding)

    Patient ventilated

    20020731

    718085007

    Unable to intubate and unable to ventilate (finding)

    Cannot intubate cannot ventilate

    20160731

    128258000

    Ventilation finding (finding)

    Ventilation finding

    20020131

    Concept id

    Fully Specified Name

    en-US Preferred Term

    Effective Time

    1157196000

    Administration of vaccine product containing only inactivated whole Severe acute respiratory syndrome coronavirus 2 antigen (procedure)

    Administration of inactivated whole SARS-CoV-2 antigen vaccine

    20210731

    Concept id

    Fully Specified Name

    en-US Preferred Term

    Effective Time

    1156256003

    Adverse reaction to component of vaccine product against Severe acute respiratory syndrome coronavirus 2 (disorder)

    Adverse reaction to COVID-19 vaccine

    20210731

    Concept id

    Fully Specified Name

    en-US Preferred Term

    Effective Time

    736017006

    Education about hand hygiene (procedure)

    Education about hand hygiene

    20180131

    Concept id

    Fully Specified Name

    en-US Preferred Term

    Effective Time

    28531000087107

    Vaccine product against Severe acute respiratory syndrome coronavirus 2 (medicinal product)

    COVID-19 vaccine

    20210731

    Concept id

    Fully Specified Name

    en-US Preferred Term

    Effective Time

    183452005

    Emergency hospital admission (procedure)

    Emergency hospital admission

    20020131

    Concept id

    Fully Specified Name

    en-US Preferred Term

    Effective Time

    40617009

    Artificial respiration (procedure)

    Artificial respiration

    20020131

    Concept id

    Fully Specified Name

    en-US Preferred Term

    Effective Time

    79031000119101

    Dependence on respirator (finding)

    Dependence on respirator

    20150731

    CV19-PTE-TreatmentEquipment

    Intensional Definition:

    < 277973009 |Respiratory equipment (physical object)| OR < 336589003 |Oxygen equipment (physical object)| OR < 334943003 |Respiratory appliances (physical object)| OR < 304077006 |Respiratory system device (physical object)| OR < 706167001 |Anesthesia and respiratory device (physical object)|

    Prevention

    Prevention Findings

    Education

    Medication

    Administrative Procedures

    Therapeutic Procedures

    Treatment Findings

    Treatment Equipment

    840534001 | SARS-CoV-2 vaccination|
    225368008 | Contact tracing|
    170499009 | Isolation of infection contact (procedure)|
    373873005 | Pharmaceutical / biologic product (product)|
    706173000 |Intensive-care ventilator (physical object)|
    464328001 |Thoracic cannula (physical object)|
    Audits in Infection Prevention and Control
    https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments

    1144997007

    1157195001

    868263005

    1157024006

    305376003

    233573008

    931000119107

    Clinical Assessment

    The first step in delivering comprehensive care is to undertake a clinical assessment. Clinical assessment data which can be recorded using SNOMED CT includes:

    • Symptoms

    • Severity

    • Clinical Measurements

    • Clinical Examination Findings

    • Diagnosis and Certainty

    • Clinical History

    • Secondary Conditions and Complications

    • Potential Risk Factors

    • Comorbidities

    • Exposure Event

    • Covid-19 and Viral Co-Infections

    These data elements are described below, with example SNOMED CT subsets for each.

    Please note that all published concepts referred to on this page are included in SNOMED International's , which is available to be used internationally under the . Please refer to for more information.

    Symptoms represent physical or mental features which are regarded as an indication of a condition or disease, particularly those features that are apparent to the patient. This SNOMED CT subset of COVID-19 symptoms has been developed based on a range of literature, including relevant articles found in Pubmed, research performed by Kings College London, and a review of COVID-19 data collection forms. Please note that this subset includes the concept , which can be used to represent the absence of symptoms.

    CV19-ASS-Symptoms

    Severity represents the quality of the condition - for example, . Severity may be recorded for each symptom, or as a general statement of their disease state 4.

    CV19-ASS-Severity

    Clinical measurements involve the performance of physiological tests to diagnose and refine therapeutic management of an already established disease. The following clinical measurements (and related observables) can be used in the assessment of a COVID-19 patient.

    CV19-ASS- ClinicalMeasurements

    Clinical examination findings are the result of measuring, questioning, evaluating, or otherwise examining a patient in healthcare. The following clinical findings are positive or negative indications that signs are present in a COVID-19 patient.

    CV19-ASS-ClinicalExaminationFindings

    A diagnosis is the identification of the nature of the illness, based on an examination of the symptoms, observations, measurements, test results and other investigation results. The following subset includes a range of diagnoses directly related to COVID-19.

    CV19-ASS-Diagnosis

    To represent the certainty of a positive COVID-19 diagnosis, the following subset may be used in conjunction with a diagnosis of .

    CV19-ASS-DiagnosisPresentCertainty

    To represent the certainty of the absence of COVID-19, the following subset may be used in conjunction with a diagnosis of .

    CV19-ASS-DiagnosisAbsentCertainty

    The clinical history concepts are used to record information gained by a physician by asking specific questions, either of the patient or of other people who know the person and can give suitable information, with the aim of obtaining information useful in formulating a diagnosis and providing medical care to the patient.

    CV19-ASS-ClinicalHistory

    A secondary condition is any additional health condition that occurs as a result of the natural progression or expected outcome of the primary condition. A complication is "a disorder caused by another disorder, procedure or event, which is not a natural progression or expected outcome of its cause .

    The following subset includes SNOMED CT clinical findings that may be recorded as either secondary conditions or complications . Clinical judgement is required to determine whether these conditions are expected outcomes or unexpected complications of COVID-19.

    CV19-ASS-SecondaryConditionsAndComplications

    Potential risk factors are the patient conditions which may influence the course or outcomes of the COVID-19 disease. The following clinical findings may be recorded as potential risk factors.

    CV19-ASS-RiskFactors

    Similarly, procedures performed on the patient within a clinically relevant timeframe may also influence the course or outcomes of the COVID-19 disease. The following procedures may be recorded as potential risk factors.

    CV19-ASS-ProcedureRiskFactors

    Comorbidities are additional medical conditions of concern. The following SNOMED CT subset can be used to record comorbidities.

    An exposure event is when an individual comes into close contact with an infected person's contaminated droplets, carried in the air or on contaminated hands, surfaces or other objects. The subset below includes SNOMED CT events for recording exposure to COVID-19.

    CV19-ASS-ExposureEvent

    An exposure finding is the result of an observation or evaluation that relates to the patient's exposure to an infection. The subset below includes SNOMED CT findings relating to COVID-19 exposure.

    CV19-ASS-ExposureFinding

    The following organism should be used when recording the organism causing COVID-19 infections.

    CV19-ASS-Organism

    The following organisms can be used to record the cause of related viral co-infections.


    Footnotes

    1 Articles found using the Pubmed query ""

    2

    3 COVID-19 Case Reporting Forms, including: , CDC, US , Global COVID-19 Clinical Platform, World Health Organization , NHS, UK

    4 , Patient.info , Patient.info

    5 , SNOMED International

    6 Clinical papers, including:

    7

    8 , NHS, UK

    9 , NHS, UK

    Bleeding (finding)

    Bleeding

    20050131

    29857009

    Chest pain (finding)

    Chest pain

    20040731

    43724002

    Chill (finding)

    Chill

    20020131

    82272006

    Common cold (disorder)

    Common cold

    20030131

    9826008

    Conjunctivitis (disorder)

    Conjunctivitis

    20040731

    49727002

    Cough (finding)

    Cough

    20020131

    3415004

    Cyanosis (finding)

    Cyanosis

    20020131

    62315008

    Diarrhea (finding)

    Diarrhea

    20020131

    3006004

    Disturbance of consciousness (finding)

    Disturbance of consciousness

    20020131

    267036007

    Dyspnea (finding)

    Dyspnea

    20020131

    271807003

    Eruption of skin (disorder)

    Eruption

    20020731

    84229001

    Fatigue (finding)

    Fatigue

    20020131

    103001002

    Feeling feverish (finding)

    Feeling feverish

    20020131

    386661006

    Fever (finding)

    Fever

    20030131

    25064002

    Headache (finding)

    Headache

    20100131

    66857006

    Hemoptysis (finding)

    Hemoptysis

    20020131

    248567008

    Indrawing of ribs during respiration (finding)

    Indrawing of ribs during respiration

    20020131

    57676002

    Joint pain (finding)

    Joint pain

    20020131

    79890006

    Loss of appetite (finding)

    Loss of appetite

    20020131

    44169009

    Loss of sense of smell (finding)

    Loss of sense of smell

    20200131

    36955009

    Loss of taste (finding)

    Loss of taste

    20020131

    30746006

    Lymphadenopathy (disorder)

    Lymphadenopathy

    20020131

    367391008

    Malaise (finding)

    Malaise

    20020131

    68962001

    Muscle pain (finding)

    Muscle pain

    20020131

    26544005

    Muscle weakness (finding)

    Muscle weakness

    20020131

    68235000

    Nasal congestion (finding)

    Nasal congestion

    20020131

    64531003

    Nasal discharge (finding)

    Nasal discharge

    20020131

    422587007

    Nausea (finding)

    Nausea

    20070131

    44077006

    Numbness (finding)

    Numbness

    20170731

    162397003

    Pain in throat (finding)

    Pain in throat

    20020131

    38880002

    Rigor (finding)

    Rigor

    20020131

    91175000

    Seizure (finding)

    Seizure

    20020131

    46742003

    Skin ulcer (disorder)

    Skin ulcer

    20020131

    23924001

    Tight chest (finding)

    Tight chest

    20020131

    282145008

    Unable to walk (finding)

    Unable to walk

    20080731

    422400008

    Vomiting (disorder)

    Vomiting

    20180731

    56018004

    Wheezing (finding)

    Wheezing

    20020131

    Moderate (severity modifier) (qualifier value)

    Moderate

    20020131

    24484000

    Severe (severity modifier) (qualifier value)

    Severe

    20020131

    442452003

    Life threatening severity (qualifier value)

    Life threatening severity

    20090731

    Body temperature (observable entity)

    Body temperature

    20170131

    75367002

    Blood pressure (observable entity)

    Blood pressure

    20170131

    248592006

    Character of cough (observable entity)

    Character of cough

    20020131

    364533002

    Color of skin (observable entity)

    Color of skin

    20020131

    709017009

    Compliance behavior to safety precaution (observable entity)

    Compliance behavior to safety precaution

    20150731

    263731006

    Coughing (observable entity)

    Coughing

    20020131

    271626009

    Depth of respiration (observable entity)

    Depth of respiration

    20020131

    226379006

    Food intake (observable entity)

    Food intake

    20020131

    364075005

    Heart rate (observable entity)

    Heart rate

    20170131

    103228002

    Hemoglobin saturation with oxygen (observable entity)

    Hemoglobin saturation with oxygen

    20020131

    6942003

    Level of consciousness (observable entity)

    Level of consciousness

    20020131

    440398005

    Level of fatigue (observable entity)

    Level of fatigue

    20090131

    405161002

    Pain level (observable entity)

    Pain level

    20040131

    248750004

    Peripheral blood flow (observable entity)

    Peripheral blood flow

    20020131

    431314004

    Peripheral oxygen saturation (observable entity)

    Peripheral oxygen saturation

    20080731

    8499008

    Pulse, function (observable entity)

    Pulse

    20020131

    248565000

    Respiratory effort (observable entity)

    Respiratory effort

    20020131

    86290005

    Respiratory rate (observable entity)

    Respiratory rate

    20170131

    248582003

    Rhythm of respiration (observable entity)

    Rhythm of respiration

    20020131

    247433003

    Skin elasticity (observable entity)

    Skin elasticity

    20020131

    248598005

    Sputum volume (observable entity)

    Sputum volume

    20020131

    442349007

    Venous oxygen saturation (observable entity)

    Venous oxygen saturation

    20090731

    Activity intolerance (finding)

    Activity intolerance

    20020131

    20262006

    Ataxia (finding)

    Ataxia

    20020131

    371632003

    Coma (disorder)

    Coma

    20020731

    193894004

    Conjunctival hyperemia (finding)

    Conjunctival hyperemia

    20100131

    58840004

    Decreased breath sounds (finding)

    Decreased breath sounds

    20020131

    443371007

    Decreased level of consciousness (finding)

    Decreased level of consciousness

    20100131

    9763007

    Expiratory wheezing (finding)

    Expiratory wheezing

    20020131

    126664009

    Exudative pharyngitis (disorder)

    Exudative pharyngitis

    20020131

    386661006

    Fever (finding)

    Fever

    20030131

    442646005

    Imaging of lung abnormal (finding)

    Imaging of lung abnormal

    20090731

    67750007

    Ineffective airway clearance (finding)

    Ineffective airway clearance

    20020131

    70944005

    Impaired gas exchange (finding)

    Impaired gas exchange

    20080731

    75252003

    Inspiratory crackles (finding)

    Inspiratory crackles

    20020131

    419045004

    Loss of consciousness (finding)

    Loss of consciousness

    20060131

    274710003

    Lung field abnormal (finding)

    Lung field abnormal

    20020131

    91175000

    Seizure (finding)

    Seizure

    20020131

    3424008

    Tachycardia (finding)

    Tachycardia

    20080731

    271823003

    Tachypnea (finding)

    Tachypnea

    20020131

    288849009

    Unable to breathe (finding)

    Unable to breathe

    20080731

    Asymptomatic severe acute respiratory syndrome coronavirus 2 infection (finding)

    Asymptomatic SARS-CoV-2

    20200731

    840539006

    Disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

    COVID-19

    20200131

    688232241000119100

    Disease caused by Severe acute respiratory syndrome coronavirus 2 absent (situation)

    Disease caused by Severe acute respiratory syndrome coronavirus 2 absent

    20200731

    840544004

    Suspected disease caused by severe acute respiratory coronavirus 2 (situation)

    Suspected COVID-19

    20200131

    Probably present (qualifier value)

    Probably present

    20040731

    415684004

    Suspected (qualifier value)

    Suspected

    20050131

    Probably NOT present (qualifier value)

    Probably NOT present

    20040731

    Acute hypoxemic respiratory failure due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

    Acute hypoxemic respiratory failure due to disease caused by Severe acute respiratory syndrome coronavirus 2

    20200731

    870589006

    Acute kidney injury due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

    Acute kidney injury due to disease caused by Severe acute respiratory syndrome coronavirus 2

    20200731

    373895009

    Acute respiratory distress (finding)

    Acute respiratory distress

    20020731

    67782005

    Acute respiratory distress syndrome (disorder)

    Acute respiratory distress syndrome

    20020131

    674814021000119106

    Acute respiratory distress syndrome due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

    Acute respiratory distress syndrome due to disease caused by Severe acute respiratory syndrome coronavirus 2

    20200731

    64779008

    Blood coagulation disorder (disorder)

    Blood coagulation disorder

    20020731

    119731000146105

    Cardiomyopathy due to disease caused by Severe acute respiratory syndrome virus 2 (disorder)

    Cardiomyopathy due to disease caused by Severe acute respiratory syndrome virus 2

    20200731

    62914000

    Cerebrovascular disease (disorder)

    Cerebrovascular disease

    20020131

    1119304009

    Chronic post-COVID-19 syndrome (disorder)

    Chronic post-COVID-19 syndrome

    20210131

    119741000146102

    Conjunctivitis due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

    Conjunctivitis due to disease caused by Severe acute respiratory syndrome coronavirus 2

    20200731

    710027002

    Cytokine-associated toxicity (disorder)

    Cytokine release syndrome

    20150731

    419099009

    Dead (finding)

    Dead

    20060131

    128053003

    Deep venous thrombosis (disorder)

    Deep venous thrombosis

    20020131

    34095006

    Dehydration (disorder)

    Dehydration

    20020131

    67406007

    Disseminated intravascular coagulation (disorder)

    Disseminated intravascular coagulation

    20020131

    3006004

    Disturbance of consciousness (finding)

    Disturbance of consciousness

    20020131

    119981000146107

    Dyspnea caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

    Dyspnea caused by Severe acute respiratory syndrome coronavirus 2

    20200731

    1240561000000108

    Encephalopathy due to disease caused by Severe acute respiratory syndrome virus 2 (disorder)

    Encephalopathy due to disease caused by Severe acute respiratory syndrome virus 2

    20200731

    119751000146104

    Fever caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

    Fever caused by Severe acute respiratory syndrome coronavirus 2

    20200731

    25374005

    Gastroenteritis (disorder)

    Gastroenteritis

    20020131

    56265001

    Heart disease (disorder)

    Heart disease

    20020131

    80394007

    Hyperglycemia (disorder)

    Hyperglycemia

    20020131

    389086002

    Hypoxia (disorder)

    Hypoxia

    20030131

    70944005

    Impaired gas exchange (finding)

    Impaired gas exchange

    20080731

    1240541000000107

    Infection of upper respiratory tract caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

    Infection of upper respiratory tract caused by Severe acute respiratory syndrome coronavirus 2

    20200731

    90708001

    Kidney disease (disorder)

    Kidney disease

    20020731

    880529761000119102

    Lower respiratory infection caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

    Lower respiratory infection caused by SARS-CoV-2

    20200731

    866151004

    Lymphocytopenia due to Severe acute respiratory syndrome coronavirus 2 (disorder)

    Lymphocytopenia due to Severe acute respiratory syndrome coronavirus 2

    20200731

    59455009

    Metabolic acidosis (disorder)

    Metabolic acidosis

    20020131

    57653000

    Multiple organ failure (disorder)

    Multiple organ failure

    20020131

    1240531000000103

    Myocarditis due to disease caused by Severe acute respiratory syndrome virus 2 (disorder)

    Myocarditis due to disease caused by Severe acute respiratory syndrome virus 2

    20200731

    1240521000000100

    Otitis media due to disease caused by Severe acute respiratory syndrome virus 2 (disorder)

    Otitis media due to disease caused by Severe acute respiratory syndrome virus 2

    20200731

    183676005

    Died in hospital (finding)

    Died in hospital

    20020131

    882784691000119100

    Pneumonia caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

    Pneumonia caused by SARS-CoV-2

    20200731

    1119303003

    Post-acute COVID-19 (disorder)

    Post-acute COVID-19

    20210131

    870591003

    Rhabdomyolysis due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

    Rhabdomyolysis due to disease caused by Severe acute respiratory syndrome coronavirus 2

    20200731

    302846007

    Rhabdomyoma (disorder)

    Rhabdomyoma

    20040731

    308906005

    Secondary bacterial pneumonia (disorder)

    Secondary bacterial pneumonia

    20160131

    91302008

    Sepsis (disorder)

    Sepsis

    20200131

    870588003

    Sepsis due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

    Sepsis due to disease caused by Severe acute respiratory syndrome coronavirus 2

    20200731

    76571007

    Septic shock (disorder)

    Septic shock

    20050131

    415623008

    Stress ulcer (disorder)

    Stress ulcer

    20050131

    238149007

    Systemic inflammatory response syndrome (disorder)

    Systemic inflammatory response syndrome

    20020131

    866152006

    Thrombocytopenia due to Severe acute respiratory syndrome coronavirus 2 (disorder)

    Thrombocytopenia due to Severe acute respiratory syndrome coronavirus 2

    20200731

    429340002

    Traumatic injury of skeletal muscle (disorder)

    Traumatic injury of skeletal muscle

    20080131

    75570004

    Viral pneumonia (disorder)

    Viral pneumonia

    20130731

    1017214008

    Viremia caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

    SARS-CoV-2 viremia

    20210131

    Chronic disease (disorder)

    Chronic disease

    20020131

    49601007

    Disorder of cardiovascular system (disorder)

    Disorder of cardiovascular system

    20020131

    414029004

    Disorder of immune function (disorder)

    Disorder of immune function

    20190131

    235856003

    Disorder of liver (disorder)

    Disorder of liver

    20020131

    118940003

    Disorder of nervous system (disorder)

    Disorder of nervous system

    20020131

    50043002

    Disorder of respiratory system (disorder)

    Disorder of respiratory system

    20020131

    722499006

    Electronic cigarette user (finding)

    Electronic cigarette user

    20170131

    8517006

    Ex-smoker (finding)

    Ex-smoker

    20020131

    80141007

    Hemoglobinopathy (disorder)

    Hemoglobinopathy

    20020131

    107921000119107

    History of immune disorder (situation)

    History of immune disorder

    20150731

    90708001

    Kidney disease (disorder)

    Kidney disease

    20020731

    363346000

    Malignant neoplastic disease (disorder)

    Malignant neoplastic disease

    20020131

    75934005

    Metabolic disease (disorder)

    Metabolic disease

    20020131

    414825006

    Neoplasm of hematopoietic cell type (disorder)

    Neoplasm of hematopoietic cell type

    20050131

    414915002

    Obese (finding)

    Obese

    20050131

    370388006

    Patient immunocompromised (finding)

    Patient immunocompromised

    20020731

    370391006

    Patient immunosuppressed (finding)

    Patient immunosuppressed

    20020731

    77386006

    Pregnant (finding)

    Pregnant

    20020131

    77176002

    Smoker (finding)

    Smoker

    20020131

    Corticosteroid and corticosteroid derivative therapy (procedure)

    Corticosteroid and corticosteroid derivative therapy

    20200131

    234336002

    Hemopoietic stem cell transplant (procedure)

    Hemopoietic stem cell transplant

    20050131

    86553008

    Immunosuppressive therapy (procedure)

    Immunosuppressive therapy

    20020131

    76334006

    Immunotherapy (procedure)

    Immunological therapy

    20020131

    108290001

    Radiation oncology AND/OR radiotherapy (procedure)

    Radiation oncology AND/OR radiotherapy

    20020131

    312235007

    Radiolabeled antibody therapy (procedure)

    Radiolabeled antibody therapy

    20020131

    265764009

    Renal dialysis (procedure)

    Renal dialysis

    20020131

    313039003

    Solid organ transplant (procedure)

    Solid organ transplant

    20060731

    Occupational exposure to Severe acute respiratory syndrome coronavirus 2 (event)

    Occupational exposure to SARS-CoV-2

    20210131

    21522001

    Abdominal pain (finding)

    Abdominal pain

    20050131

    84387000

    Asymptomatic (finding)

    Asymptomatic

    20020131

    84387000

    Asymptomatic (finding)

    Asymptomatic

    20020131

    255604002

    Mild (qualifier value)

    Mild

    20020131

    413384008

    Ability to perform cognitive activity (observable entity)

    Ability to perform cognitive activity

    20050131

    442476006

    Arterial oxygen saturation (observable entity)

    Arterial oxygen saturation

    20090731

    Concept id

    Fully Specified Name

    en-US Preferred Term

    Effective Time

    288848001

    Able to breathe (finding)

    Able to breathe

    20080731

    Concept id

    Fully Specified Name

    en-US Preferred Term

    Effective Time

    1119302008

    Acute disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)

    Acute COVID-19

    20210131

    Concept id

    Fully Specified Name

    en-US Preferred Term

    Effective Time

    410605003

    Confirmed present (qualifier value)

    Confirmed present

    20040731

    Concept id

    Fully Specified Name

    en-US Preferred Term

    Effective Time

    410594000

    Definitely NOT present (qualifier value)

    Definitely NOT present

    20040731

    Concept id

    Fully Specified Name

    en-US Preferred Term

    Effective Time

    In GPS

    292508471000119105

    History of disease caused by severe acute respiratory syndrome coronavirus 2 (situation)

    History of SARS-CoV-2

    20200731

    Concept id

    Fully Specified Name

    en-US Preferred Term

    Effective Time

    138389411000119105

    Acute bronchitis caused by severe acute respiratory syndrome coronavirus 2 (disorder)

    Acute bronchitis caused by SARS-CoV-2

    20200731

    Concept id

    Fully Specified Name

    en-US Preferred Term

    Effective Time

    78648007

    At risk for infection (finding)

    At risk for infection

    20020131

    Concept id

    Fully Specified Name

    en-US Preferred Term

    Effective Time

    367336001

    Chemotherapy (procedure)

    Chemotherapy

    20020131

    CV19-ASS-Comorbidities

    Intensional Definition:

    < 64572001 |Disease (disorder)|

    Concept id

    Fully Specified Name

    en-US Preferred Term

    Effective Time

    840546002

    Exposure to severe acute respiratory syndrome coronavirus 2 (event)

    Exposure to SARS-CoV-2

    20200131

    Concept id

    Fully Specified Name

    en-US Preferred Term

    Effective Time

    870577009

    At increased risk of exposure to severe acute respiratory syndrome coronavirus 2 (finding)

    At increased risk of exposure to severe acute respiratory syndrome coronavirus 2

    20200731

    Concept id

    Fully Specified Name

    en-US Preferred Term

    Effective Time

    840533007

    Severe acute respiratory syndrome coronavirus 2 (organism)

    SARS-CoV-2

    20200131

    CV19-ASS-ViralCoInfections

    Intensional Definition:

    << 49872002 |Virus (organism)| MINUS 840533007 |Severe acute respiratory syndrome coronavirus 2 (organism)|

    Symptoms

    Severity

    Clinical Measurements

    Clinical Examination Findings

    Diagnosis and Certainty

    Clinical History

    Secondary Conditions and Complications

    Potential Risk Factors

    Comorbidities

    Exposure

    Covid-19 and Viral Co-Infections

    Global Patient Set (GPS)
    Creative Commons Attribution 4.0 International License
    http://snomed.org/covid-19
    84387000 | Asymptomatic (finding)|
    24484000 | Severe (severity modifier) (qualifier value)|
    840539006 | COVID-19|
    688232241000119100 | Disease caused by severe acute respiratory syndrome coronavirus 2 absent (situation)|
    https://pubmed.ncbi.nlm.nih.gov/?term=covid+19&filter=pubt.review
    COVID Symptom Tracker Research Updates
    COVID-19 Case Report Form
    Novel Coronavirus (COVID-19) Case Record Form
    COVID-19 Hospitalisation in England Surveillance System (CHESS) Daily Reporting
    Coronavirus: what are asymptomatic and mild COVID-19?
    Coronavirus: what are moderate, severe and critical COVID-19?
    SNOMED CT Editorial Guide
    COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission
    COVID-19 and the Cardiovascular System
    Caution on Kidney Dysfunctions of COVID-19 Patients
    Holistic care for patients with severe coronavirus disease 2019: An expert consensus
    Rhabdomyolysis as Potential Late Complication Associated with COVID-19
    Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: A Retrospective Case Series Study
    Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China
    CHESS Daily Reporting
    COVID-19 - High Risk Shielded Patient List Identification Methodology - Clinical Inclusion Criteria

    131148009

    6736007

    386725007

    77427003

    189486241000119100

    410592001

    410593006

    -

    870590002

    27624003

    788751009

    897036007